Home8F8 • FRA
add
SynAct Pharma AB
Previous close
€1.53
Day range
€1.50 - €1.66
Year range
€0.53 - €1.66
Market cap
950.28M SEK
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.80M | 26.77% |
Net income | -18.38M | 79.70% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.15M | -196.05% |
Effective tax rate | 9.54% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.21M | -1.90% |
Total assets | 270.52M | 18.64% |
Total liabilities | 56.35M | 8.72% |
Total equity | 214.17M | — |
Shares outstanding | 41.75M | — |
Price to book | 0.30 | — |
Return on assets | -21.32% | — |
Return on capital | -26.89% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -18.38M | 79.70% |
Cash from operations | -17.78M | 12.83% |
Cash from investing | — | — |
Cash from financing | 40.20M | -26.32% |
Net change in cash | 22.72M | -32.21% |
Free cash flow | -8.74M | -114.10% |
About
Founded
Mar 14, 2012
Website
Employees
5
